title: Reply: To PMID 25545787.
authors.affiliation: Multi-Organ Transplant Institute, Ochsner Medical Center, New Orleans, LA.
authors.forename: John B
authors.initials: JB
authors.lastname: Seal
authors.affiliation: Multi-Organ Transplant Program, Department of Surgery, Toronto General Hospital, Toronto, ON, Canada.
authors.forename: Markus
authors.initials: M
authors.lastname: Selzner
authors.affiliation: Multi-Organ Transplant Institute, Ochsner Medical Center, New Orleans, LA.
authors.forename: George
authors.initials: G
authors.lastname: Loss
mesh_terms: D002779:Cholestasis / Q000517:prevention & control*; D005260:Female; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007511:Ischemia / Q000517:prevention & control*; D016031:Liver Transplantation / Q000009:adverse effects*; D008297:Male; D015912:Thrombolytic Therapy / Q000379:methods*; D014019:Tissue Donors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator